CCK - Spark Newswire

1 minute read

Analyst Ratings

What 5 Analyst Ratings Have To Say About Crown Holdings

September 7, 2:06 PM

Over the past 3 months, 5 analysts have published their opinion on Crown Holdings (NYSE:CCK) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

CCK

2 minute read

Clorox, Crocs And Some Other Big Stocks Moving Lower On Thursday

By Lisa Levin

August 4, 2:02 PM

AMTD Digital Inc. (NYSE: HKD) dipped 43.6% to $620.00 on possible profit taking after the stock surged over the last few trading days.

AGO

6 minute read

Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

August 4, 1:12 PM

Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday.

ACA

2 minute read

Analyst Ratings

Morgan Stanley Maintains Overweight Rating for Crown Holdings: Here’s What You Need To Know

By Benzinga Insights

July 26, 12:28 PM

Morgan Stanley has decided to maintain its Overweight rating of Crown Holdings (NYSE:CCK) and lower its price target from $135.00 to $130.00. Shares of Crown Holdings are trading down 0.43% over the last 24 hours, at $95.23 per share.

CCK

1 minute read

Analyst Ratings

8 Analysts Have This to Say About Crown Holdings

By Benzinga Insights

July 22, 12:15 PM

Within the last quarter, Crown Holdings (NYSE:CCK) has observed the following analyst ratings:

CCK

1 minute read

Crown Holdings Cuts FY22 Earnings Forecast Despite Q2 Beat

By Shivani Kumaresan

July 21, 6:14 AM

Crown Holdings Inc (NYSE:CCK) reported second-quarter FY22 sales growth of 22.9% year-on-year, to $3.51 billion, beating the consensus of $3.21 billion.…

CCK

1 minute read

Crown Holdings Q2 EPS $2.10 Beats $2.03 Estimate, Sales $3.51B Beat $3.21B Estimate

By Michael Horton

July 20, 4:53 PM

Crown Holdings (NYSE:CCK) reported quarterly earnings of $2.10 per share which beat the analyst consensus estimate of $2.03 by 3.45 percent. This is a 1.87 percent decrease over earnings of $2.14 per share from the same

CCK